Risk factors for new-onset diabetes mellitus in adult liver transplant recipients, an analysis of the organ procurement and transplant network/united network for organ sharing database

Transplantation

Volumn 89, Issue 9, 2010, Pages 1134-1140

  Kuo, Hung Tien ^a,b   Sampaio, Marcelo Santos ^a,c   Ye, Xiaoyi ^a   Reddy, Pavani ^a   Martin, Paul ^d   Bunnapradist, Suphamai ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes mellitus; Liver transplant; Posttransplant complications; Risk factors

Indexed keywords

CYCLOSPORIN; TACROLIMUS;

ADULT; AFRICAN AMERICAN; AGE; ARTICLE; BODY MASS; DIABETES MELLITUS; FEMALE; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CIRCULATION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; REGISTER; RISK FACTOR;

ADULT; AGED; BODY MASS INDEX; CONTINENTAL POPULATION GROUPS; DIABETES MELLITUS; FEMALE; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; YOUNG ADULT;

EID: 77951880020     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181d2fec1     Document Type: Article

References (40)

1. Chen T, Jia H, Li J, et al. New onset diabetes mellitus after liver transplantation and hepatitis C virus infection: Meta-analysis of clinical studies. Transpl Int 2009; 22: 408.
2. Marchetti P. New-onset diabetes after transplantation. J Heart Lung Transplant 2004; 23(5 suppl): S194.
3. Shah T, Kasravi A, Huang E, et al. Risk factors for development of new-onset diabetes mellitus after kidney transplantation. Transplantation 2006; 82: 1673.
4. Cosio FG, Hickson LJ, Griffin MD, et al. Patient survival and cardiovascular risk after kidney transplantation: The challenge of diabetes. Am J Transplant 2008; 8: 593.
5. Cosio FG, Pesavento TE, Kim S, et al. Patient survival after renal transplantation. IV. Impact of post-transplant diabetes. Kidney Int 2002; 62: 1440.
6. Friedman EA, Shyh TP, Beyer MM, et al. Posttransplant diabetes in kidney transplant recipients. Am J Nephrol 1985; 5: 196.
7. Kasiske BL, Snyder JJ, Gilbertson D, etal. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003; 3: 178.
8. Vesco L, Busson M, Bedrossian J, et al. Diabetes mellitus after renal transplantation: Characteristics, outcome, and risk factors. Transplantation 1996; 61: 1475.
9. Oufroukhi L, Kamar N, Muscari F, et al. Predictive factors for post-transplant diabetes mellitus within one-year of liver transplantation. Transplantation 2008; 85: 1436
10. Thuluvath PJ.Isthere a link between hepatitis C virus and new onset of diabetes mellitus after liver transplantation? Liver Transpl 2007; 13: 5.
11. Saliba F, Lakehal M, Pageaux GP, et al. Risk factors for new-onset diabetes mellitus following liver transplantation and impact of hepatitis C infection: An observational multicenter study. Liver Transpl 2007; 13: 136.
12. Gaynor JJ, Moon JI, Kato T, et al. A cause-specific hazard rate analysis of prognostic factors among 877 adults who received primary ortho-topic liver transplantation. Transplantation 2007; 84: 155.
13. Moon JI, Barbeito R, Faradji RN, et al. Negative impact of new-onset diabetes mellitus on patient and graft survival after liver transplantation: Long-term follow up. Transplantation 2006; 82: 1625.
14. Kishi Y, Sugawara Y, Tamura S, et al. New-onset diabetes mellitus after living donor liver transplantation: Possible association with hepatitis C. Transplant Proc 2006; 38: 2989.
15. Driscoll CJ, Cashion AK, Hathaway DK, et al. Posttransplant diabetes mellitus in liver transplant recipients. Prog Transplant 2006; 16: 110.
16. Mirabella S, Brunati A, Ricchiuti A, et al. New-onset diabetes after liver transplantation. Transplant Proc 2005; 37: 2636.
17. Khalili M, Lim JW, Bass N, et al. New onset diabetes mellitus after liver transplantation: The critical role of hepatitis C infection. Liver Transpl 2004; 10: 349.
18. Parolin MB, Zaina FE, Araujo MV, et al. Prevalence of new-onset diabetes mellitus in Brazilian liver transplant recipients: Association with HCV infection. Transplant Proc 2004; 36: 2776.
19. Sumrani NB, Delaney V, Ding ZK, et al. Diabetes mellitus after renal transplantation in the cyclosporine era\An analysis of risk factors. Transplantation 1991; 51: 343.
20. Leonard J, Heimbach JK, Malinchoc M, et al. The impact of obesity on long-term outcomes in liver transplant recipients-results of the NIDDK liver transplant database. Am J Transplant 2008; 8: 667.
21. Alsatie M, Pandya P, Chalasani NP. Insulin resistance, hepatitis C, and liver transplantation. Liver Transpl 2008; 14: 136.
22. Bloom RD, Crutchlow MF. Transplant-associated hyperglycemia. Transplant Rev (Orlando) 2008; 22: 39.
23. Delgado-Borrego A, Liu YS, Jordan SH, et al. Prospective study of liver transplant recipients with HCV infection: Evidence for a causal relationship between HCV and insulin resistance. Liver Transpl 2008; 14: 193.
24. Baid S, Cosimi AB, Farrell ML,et al. Posttransplant diabetes mellitus in liver transplant recipients: Risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation 2001; 72: 1066.
25. Picardi A, D'Avola D, Gentilucci UV, et al. Diabetes in chronic liver disease: From old concepts to new evidence. Diabetes Metab Res Rev 2006; 22: 274.
26. Konrad T, Steinmuller T, Vicini P, et al. Evidence for impaired glucose effectiveness in cirrhotic patients after liver transplantation. Metabolism 2000; 49: 367.
27. Ahmad M, Cole EH, Cardella CJ, et al. Impact of deceased donor diabetes mellitus on kidney transplant outcomes: A propensity score-matched study. Transplantation 2009; 88: 251.
28. Ojo AO, Leichtman AB, Punch JD, et al. Impact of pre-existing donor hypertension and diabetes mellitus on cadaveric renal transplant outcomes. Am J Kidney Dis 2000; 36: 153.
29. Washburn WK, Johnson LB, Lewis WD, et al. Graft function and outcome of older (> or = 60 years) donor livers. Transplantation 1996; 61: 1062.
30. Busquets J, Xiol X, Figueras J, et al. The impact of donor age on liver transplantation: Influence of donor age on early liver function and on subsequent patient and graft survival. Transplantation 2001; 71: 1765.
31. Hjelmesaeth J, Hartmann A, Kofstad J, et al. Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation 1997; 64: 979.
32. Johnston O, Rose CL, Webster AC, et al. Sirolimus is associated with new-onset diabetes in kidney transplant recipients. J Am Soc Nephrol 2008; 19: 1411.
33. Ericzon B, Groth C, Bismuth H, et al. Glucose metabolism in liver transplant recipients treated with FK 506 or cyclosporin in the European multicentre study. TransplInt 1994; 7(suppl 1): S11.
34. Levy G, Grazi GL, Sanjuan F, et al. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus. Liver Transpl 2006; 12: 1464.
35. Becker T, Foltys D, Bilbao I, et al. Patient outcomes in two steroid-free regimens using tacrolimus monotherapy after daclizumab induction and tacrolimus with mycophenolate mofetil in liver transplantation. Transplantation 2008; 86: 1689.
36. Boillot O, Mayer DA, Boudjema K, et al. Corticosteroid-free immuno-suppression with tacrolimus following induction with daclizumab: A large randomized clinical study. Liver Transpl 2005; 11: 61.
37. Kato T, Gaynor JJ, Yoshida H, et al. Randomized trial of steroid-free induction versus corticosteroid maintenance among orthotopic liver transplant recipients with hepatitis C virus: Impact on hepatic fibrosis progression at one year. Transplantation 2007; 84: 829.
38. Llado L, Xiol X, Figueras J, et al. Immunosuppression without steroids in liver transplantation is safe and reduces infection and metabolic complications: Results from a prospective multicenter randomized study. J Hepatol 2006; 44: 710.
39. Trail KC, McCashland TM, Larsen JL, et al. Morbidity in patients with posttransplant diabetes mellitus following orthotopic liver transplantation. Liver Transpl Surg 1996; 2: 276.
40. John PR, Thuluvath PJ. Outcome of patients with new-onset diabetes mellitus after liver transplantation compared with those without diabetes mellitus. Liver Transpl 2002; 8: 708.